Skakodub, Anna
Walch, Henry http://orcid.org/0000-0003-1188-350X
Tringale, Kathryn R.
Eichholz, Jordan
Imber, Brandon S. http://orcid.org/0000-0002-1281-5915
Vasudevan, Harish N.
Li, Bob T. http://orcid.org/0000-0001-6661-8733
Moss, Nelson S.
Hei Yu, Kenny Kwok http://orcid.org/0000-0002-2394-4990
Mueller, Boris A.
Powell, Simon http://orcid.org/0000-0002-8183-4765
Razavi, Pedram http://orcid.org/0000-0003-4236-0576
Yu, Helena A. http://orcid.org/0000-0002-0377-9510
Reis-Filho, Jorge S. http://orcid.org/0000-0003-2969-3173
Gomez, Daniel
Schultz, Nikolaus http://orcid.org/0000-0002-0131-4904
Pike, Luke R. G. http://orcid.org/0000-0001-9622-7442
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (P30 CA008748)
Article History
Received: 28 March 2023
Accepted: 10 August 2023
First Online: 17 August 2023
Competing interests
: B.S.I.: GT Medical Technologies, Inc., Provision of Services; B.T.L.: Amgen, Provision of Services (uncompensated), Asia Society, Provision of Services (uncompensated), AstraZeneca, Provision of Services (uncompensated), BeiGene, Ltd., Provision of Services (uncompensated), Bolt Biotherapeutics, Inc., Provision of Services (uncompensated), Daiichi Sankyo, Provision of Services (uncompensated), Karger Publishers Intellectual, Property Rights, Roche, Provision of Services (uncompensated), Shanghai Jiao Tong University Press Co., Ltd., Intellectual Property Rights; N.S.M.: AstraZeneca, Provision of Services; K.K.H.U.: Aptorum Group Limited, Ownership / Equity Interests; S.P.: PharmaPier US LLC, Provision of Services (uncompensated), Rain Therapeutics Inc., Provision of Services, Varian Medical Systems, Provision of Services; Razavi: Biovica, Provision of Services, Inivata, Inc., Provision of Services, Novartis, Provision of Services, Tempus Labs, Inc., Provision of Services (uncompensated); H.A.Y.: AstraZeneca, Provision of Services, Black Diamond Therapeutics, Inc., Provision of Services, Blueprint Medicines, Provision of Services, C4 Therapeutics, Provision of Services, Daiichi Sankyo, Provision of Services, Janssen Pharmaceuticals, Inc., Provision of Services; J.S.R.: Belgian Volition, Provision of Services, Goldman Sachs, Provision of Services, Oncoclinicas do Brasil Servicos Medicos S.A., Fiduciary Role/Position; Ownership / Equity Interests, Paige.AI, Inc., Ownership / Equity Interests; Provision of Services, Personalis, Inc., Provision of Services, Repare Therapeutics, Ownership / Equity Interests; Provision of Services; D.G.: Grail, Provision of Services, Johnson & Johnson, Provision of Services (uncompensated), Med Learning Group, Provision of Services, Medtronic, Provision of Services, Varian Medical Systems, Provision of Services; N.S.: Cambridge Innovation Institute, Provision of Services (uncompensated), Harvard T.H. Chan School of Public Health, Provision of Services (uncompensated), Innovation in Cancer Informatics, Provision of Services (uncompensated), Seoul National University, Provision of Services; L.R.P.: Best Doctors, Provision of Services, Clovis Oncology, Ownership / Equity Interests, Galera Therapeutics, Inc., Provision of Services, Monte Rosa Therapeutics, Inc., Provision of Services, Turnstone Biologics Corp., Provision of Services. The remaining authors declare no competing interests.